INTECH Investment Management’s Nuvation Bio NUVB Stock Holding History

INTECH Investment Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$323K	Sell	56,894 -1,985	-3%	-$9.7K	﹤0.01%	1542
2026 Q1	$253K	Sell	58,879 -31,536	-35%	-$176K	﹤0.01%	1649
2025 Q4	$810K	Sell	90,415 -7,402	-8%	-$45.9K	0.01%	1241
2025 Q3	$362K	Sell	97,817 -29,357	-23%	-$80K	﹤0.01%	1737
2025 Q2	$248K	Buy	127,174 +11,212	+10%	+$23.4K	﹤0.01%	1983
2025 Q1	$204K	Buy	115,962 +39,456	+52%	+$89.8K	﹤0.01%	2086
2024 Q4	$204K	Buy	76,506 +18,650	+32%	+$48K	﹤0.01%	2021
2024 Q3	$132K	Buy	+57,856	New	+$176K	﹤0.01%	1834

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

INTECH Investment Management's NUVB Position: Q2 2026 in Review

INTECH Investment Management reduced its Nuvation Bio (NUVB) stake by 3.4% in Q2 2026, selling an estimated $9.7K and leaving 56,894 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

INTECH Investment Management first reported a position in NUVB in Q3 2024 and has held it in 8 quarters since. The position peaked at $810K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

INTECH Investment Management held 56,894 shares of Nuvation Bio worth $323K as of Q2 2026.
INTECH Investment Management sold 1,985 Nuvation Bio shares in Q2 2026, an estimated $9.7K.
Nuvation Bio made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1542 holding.
INTECH Investment Management first reported a position in Nuvation Bio in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Nuvation Bio position peaked at $810K in Q4 2025.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.